Archer-Daniels-Midland Co vs Cytokinetics Inc — how do they compare? Archer-Daniels-Midland Co trades at $80.23 (market cap $38.79B), while Cytokinetics Inc trades at $77.39 (market cap $10.78B). The key difference: Archer-Daniels-Midland Co is far larger — about 3.6× Cytokinetics Inc's market cap, and Archer-Daniels-Midland Co pays a 2.58% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| ADM | CYTK | |
|---|---|---|
Market Cap | $38.79B | $10.78B |
Sector | Consumer Staples | Technology |
52-Week High | $87.32 | $87.26 |
52-Week Low | $56.00 | $34.31 |
Enterprise Value | $47.04B | $10.88B |
Dividend Yield | 2.58% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.
The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.
Trailing returns across standard periods
Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. Additionally, the company owns an extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients. The company is also a large producer of corn-based sweeteners, starches, and ethanol.
Read more on ADM →Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →